Literature DB >> 12927795

Susceptibility to programmed cell death in T-lymphocytes from septic patients: a mechanism for lymphopenia and Th2 predominance.

Georg Roth1, Bernhard Moser, Claus Krenn, Markus Brunner, Markus Haisjackl, Gabriele Almer, Sabine Gerlitz, Ernst Wolner, George Boltz-Nitulescu, Hendrik J Ankersmit.   

Abstract

Sepsis causes lymphopenia which is inversely correlated with patient survival. The role of apoptosis-specific immune-activation and activation-induced cell-death in sepsis is incompletely understood. Fifteen septic patients and 20 healthy controls were included. T-cell proliferation was measured by [3H]thymidine uptake. Apoptosis and cell phenotype were determined by FACS. sTNFR1, sCD95, interleukin-1beta converting enzyme (sICE), and interleukin (IL)-10 were measured by ELISA. PHA and CD3-driven T-cell proliferation were significantly decreased in septic patients. The percentages of CD3(+) and CD4(+) T cells and CD19(+) B cells were significantly reduced. Percent memory T-cells (CD45RO(+)) and cells undergoing apoptosis (CD95(+)/annexin-V(+)) were significantly increased in sepsis. Moreover, sCD95, sTNFRI, and ICE were significantly increased. Anti-CD3 antibody triggering induced a 56% increase of CD4 T-cell death in septic patients vs. 7.5% in controls relative to IgG. Serum level of IL-10, a Th2 cytokine, was enhanced. These findings strongly suggest that in septic patients Th1 T-cells are selectively susceptible to undergo apoptosis. This observation provides an additional pathophysiological concept in the genesis of Th2 dominance.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12927795     DOI: 10.1016/s0006-291x(03)01482-7

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  43 in total

Review 1.  Epigenetic regulation of immune cell functions during post-septic immunosuppression.

Authors:  William F Carson; Karen A Cavassani; Yali Dou; Steven L Kunkel
Journal:  Epigenetics       Date:  2011-03-01       Impact factor: 4.528

Review 2.  Role of cellular events in the pathophysiology of sepsis.

Authors:  Chandra Bhan; Pankaj Dipankar; Papiya Chakraborty; Pranita P Sarangi
Journal:  Inflamm Res       Date:  2016-07-08       Impact factor: 4.575

3.  Effects of murine endotoxemia on lymphocyte subsets and clearance of staphylococcal pulmonary infection.

Authors:  M Holub; D A Lawrence; T K Mondal
Journal:  Folia Microbiol (Praha)       Date:  2006       Impact factor: 2.099

4.  Alterations of T helper lymphocyte subpopulations in sepsis, severe sepsis, and septic shock: a prospective observational study.

Authors:  Jia Li; Ming Li; Longxiang Su; Huijuan Wang; Kun Xiao; Jie Deng; Yanhong Jia; Gencheng Han; Lixin Xie
Journal:  Inflammation       Date:  2015       Impact factor: 4.092

5.  Relation between lymphopenia and bacteraemia in UK adults with medical emergencies.

Authors:  D H Wyllie; I C J W Bowler; T E A Peto
Journal:  J Clin Pathol       Date:  2004-09       Impact factor: 3.411

6.  Immune status in sepsis: the bug, the site of infection and the severity can make the difference.

Authors:  Jean-Marc Cavaillon; Minou Adib-Conquy
Journal:  Crit Care       Date:  2010-06-18       Impact factor: 9.097

7.  Sustained and incomplete recovery of naive CD8+ T cell precursors after sepsis contributes to impaired CD8+ T cell responses to infection.

Authors:  Stephanie A Condotta; Deepa Rai; Britnie R James; Thomas S Griffith; Vladimir P Badovinac
Journal:  J Immunol       Date:  2013-01-25       Impact factor: 5.422

8.  Clinical relevance of the severe abnormalities of the T cell compartment in septic shock patients.

Authors:  Jorge Monserrat; Raul de Pablo; Eduardo Reyes; David Díaz; Hugo Barcenilla; Manuel R Zapata; Antonio De la Hera; Alfredo Prieto; Melchor Alvarez-Mon
Journal:  Crit Care       Date:  2009-02-25       Impact factor: 9.097

9.  Cell death serum biomarkers are early predictors for survival in severe septic patients with hepatic dysfunction.

Authors:  Stefan Hofer; Thorsten Brenner; Christian Bopp; Jochen Steppan; Christoph Lichtenstern; Jürgen Weitz; Thomas Bruckner; Eike Martin; Ursula Hoffmann; Markus A Weigand
Journal:  Crit Care       Date:  2009-06-18       Impact factor: 9.097

10.  VX-166: a novel potent small molecule caspase inhibitor as a potential therapy for sepsis.

Authors:  Peter Weber; Ping Wang; Stephane Maddens; Paul Sh Wang; Rongqian Wu; Michael Miksa; Weifeng Dong; Michael Mortimore; Julian M C Golec; Peter Charlton
Journal:  Crit Care       Date:  2009-09-09       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.